Novavax Inc (NVAX)

R&D Expenses

$338.42M

TTM · Period ending: · USD

NVAX logo

NVAX R&D Expenses

Latest reported$338.42M
NVAX TTM R&D Expenses ($3.70M → $338.42M)
High-resolution chart · PNG

NVAX r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Novavax Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
12,150,000
10,426,000
9,358,000
7,761,000
5,937,000
4,424,000
3,400,000
3,500,000
3,300,000
3,400,000
3,500,000
3,100,000
2,900,000
3,000,000
3,000,000
3,300,000
3,400,000
3,500,000
3,700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.